DEAR DR. ROACH: I’m a 75-year-old woman who, for at least 10 years now, has been experiencing a rapid heart rate. My blood ...
HeartBeam has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...
The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...
As per a survey, only a fraction of smartwatch users share details of their health stats with a doctor, a misstep that could ...
A new treatment at Unity Point Health is offering promising results for those with irregular heartbeats, otherwise known as ...
Currently, Garmin’s ECG functionality only extends to on-the-spot readings and works to distinguish between normal sinus rhythms and signs of atrial fibrillation (AFib).
HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...
The atrial fibrillation (AF) device market is experiencing rapid growth, fueled by the rising prevalence of atrial fibrillation, increasing awareness of early diagnosis, and advancements in medical ...